Abstract
Background
Epicardial fat thickness (EFT) has been evaluated as a marker of cardiovascular disease, with good correlation with classical cardiovascular risk factors in the general population. The aim of this study was to evaluate the EFT in subclinical hypothyroidism (SCH), in comparison to a group without thyroid dysfunction.
Methods
A cross-sectional study was performed with 100 participants, including 52 SCH patients and 48 individuals without any thyroid dysfunction (euthyroid group-EU). Transthoracic echocardiography (TE), thyroid hormone levels, lipid profile, and assessment of body composition by bioelectrical impedance (BIA) and anthropometry were measured in all subjects.
Results
The SCH and EU groups were comparable with respect to age, gender, and Framingham risk scores. Serum thyroid-stimulating hormone (TSH) was 6.7 ± 1.4 mIU/L in the SCH group and 2.0 ± 0.84 mIU/L in the control group. EFT was similar in both groups (SCH 3.5 ± 1.3 mm, EU 3.5 ± 1.1 mm, p = 0.43). EFT showed a slight trend for a positive correlation with serum TSH in the SCH group (r s = 0.263, p = 0.05). EFT correlated with the body fat percentage in the SCH group (r s = 0.350, p = 0.03) and EU group (r s = 0.033, p = 0.04). EFT in this cohort was not independently correlated to changes in TSH and Framingham risk score.
Conclusions
EFT determination by TE does not seem to be a good marker of cardiovascular risk in SCH patients with serum TSH <10.0 mIU/L and no pre-existing cardiovascular morbidity.
Similar content being viewed by others
References
Cooper DS (2001) Clinical practice. Subclinical hypothyroidism. N Engl J Med 345:260–265
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC (2000) The Colorado thyroid disease prevalence study. Arch Intern Med 160:526–534
Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132:270–278
Jung CH, Sung KC, Shin HS, Rhee EJ, Lee WY, Kim BS et al (2003) Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. Korean J Intern Med 18:146–153
Asvold BO, Vatten LJ, Nilsen TI, Bjoro T (2007) The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol 156:181–186
Maratou E, Hadjidakis DJ, Kollias A, Tsegka K, Peppa M, Alevizaki M et al (2009) Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 160:785–790
Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL et al (2006) Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295:1033–1041
Walsh JP, Bremner AP, Bulsara MK, O’Leary P, Leedman PJ, Feddema P et al (2005) Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 165:2467–2472
Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP et al (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304:1365–1374
Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB et al (2005) Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165:2460–2466
Ferreira MM, Teixeira PF, Mansur VA, Reuters VS, Almeida CP, Vaisman M (2010) Ambulatory blood pressure monitoring in normotensive patients with subclinical hypothyroidism. Arq Bras Cardiol 94:806–812
Liu D, Jiang F, Shan Z, Wang B, Wang J, Lai Y et al (2010) A cross-sectional survey of relationship between serum TSH level and blood pressure. J Hum Hypertens 24:134–138
Razvi S, Weaver JU, Vanderpump MP, Pearce SH (2010) The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham survey cohort. J Clin Endocrinol Metab 95:1734–1740
Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR et al (2001) TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (basel thyroid study). J Clin Endocrinol Metab 86:4860–4866
Danese MD, Ladenson PW, Meinert CL, Powe NR (2000) Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 85:2993–3001
Silva N, Santos O, Morais F, Gottlieb I, Hadlich M, Rothstein T et al (2014) Subclinical hypothyroidism represents an additional risk factor for coronary artery calcification, especially in subjects with intermediate and high cardiovascular risk scores. Eur J Endocrinol 171:327–334
Momesso DP, Bussade I, Epifanio MA, Schettino CD, Russo LA, Kupfer R (2011) Increased epicardial adipose tissue in type 1 diabetes is associated with central obesity and metabolic syndrome. Diabetes Res Clin Pract 91:47–53
Cooper DS, Biondi B (2012) Subclinical thyroid disease. Lancet 379:1142–1154
McQuade C, Skugor M, Brennan DM, Hoar B, Stevenson C, Hoogwerf BJ (2011) Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study. Thyroid 21:837–843
Razvi S, Shakoor A, Vanderpump M, Weaver JU, Pearce SH (2008) The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab 93:2998–3007
Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U et al (2003) Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 11:304–310
Iacobellis G, Willens HJ (2009) Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 22:1311–1319 (quiz 1417–1318)
Jeong JW, Jeong MH, Yun KH, Oh SK, Park EM, Kim YK et al (2007) Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 71:536–539
Ueno K, Anzai T, Jinzaki M, Yamada M, Jo Y, Maekawa Y et al (2009) Increased epicardial fat volume quantified by 64-multidetector computed tomography is associated with coronary atherosclerosis and totally occlusive lesions. Circ J 73:1927–1933
Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH et al (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291:228–238
Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI et al (2012) Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 18:988–1028
Braulio VB, Furtado VC, Silveira M, Fonseca MH, Oliveira JE (2010) Comparison of body composition methods in overweight and obese Brazilian women. Arq Bras Endocrinol Metabol 54:398–405
Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB (1988) Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr 47:7–14
Iacobellis G, Willens HJ, Barbaro G, Sharma AM (2008) Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity (Silver Spring) 16:887–892
de Moura Souza A, Sichieri R (2011) Association between serum TSH concentration within the normal range and adiposity. Eur J Endocrinol 165:11–15
Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L et al (2005) Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 90:4019–4024
Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M et al (2004) Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab 89:3365–3370
Sgarbi JA, Teixeira PF, Maciel LM, Mazeto GM, Vaisman M, Montenegro Junior RM et al (2013) The Brazilian consensus for the clinical approach and treatment of subclinical hypothyroidism in adults: recommendations of the thyroid Department of the Brazilian Society of Endocrinology and Metabolism. Arq Bras Endocrinol Metabol 57:166–183
Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS et al (2006) Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 5:1
Janik M, Hartlage G, Alexopoulos N, Mirzoyev Z, McLean DS, Arepalli CD et al (2010) Epicardial adipose tissue volume and coronary artery calcium to predict myocardial ischemia on positron emission tomography-computed tomography studies. J Nucl Cardiol 17:841–847
Korkmaz L, Sahin S, Akyuz AR, Ziyrek M, Anaforoglu I, Kose M et al (2013) Epicardial adipose tissue increased in patients with newly diagnosed subclinical hypothyroidism. Med Princ Pract 22:42–46
Asik M, Sahin S, Ozkul F, Anaforoglu I, Ayhan S, Karagol S et al (2013) Evaluation of epicardial fat tissue thickness in patients with Hashimoto thyroiditis. Clin Endocrinol (Oxf) 79:571–576
Conflict of interest
Authors disclose no conflicts of interest regarding this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Santos, O.C., Silva, N.A.O., Vaisman, M. et al. Evaluation of epicardial fat tissue thickness as a marker of cardiovascular risk in patients with subclinical hypothyroidism. J Endocrinol Invest 38, 421–427 (2015). https://doi.org/10.1007/s40618-014-0199-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-014-0199-x